HHS Proposes Clinical Trial Reform To Catch Chinese Biotech Sector

The Department of Health and Human Services has rolled out a plan to speed up clinical trials, aiming to keep pace with China's rapidly growing biotech industry. This move is crucial as the U.S. seeks to maintain its leadership in innovative medical research and development. By expediting the trial process, the U.S. hopes to bolster its biotech sector, ensuring it can compete more effectively on a global stage, particularly against China's advancements. This reform could significantly impact how new drugs and treatments are developed and approved, potentially benefiting public health worldwide.